Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction

Dania V. Rossi, Marisela Valdez, Georgianna G Gould, Julie G. Hensler

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

In this study venlafaxine was administered to rats at a low, moderate or high dose; for comparison, the selective serotonin reuptake inhibitor (SSRI) sertraline and the tricyclic antidepressant (TCA) amitriptyline were also included. We evaluated, using quantitative autoradiography, the effect of these antidepressant treatments on [35S]GTPγS binding stimulated by the 5-HT1A receptor agonist 8-OH-DPAT, a measure of the capacity of 5-HT1A receptors to activate G proteins. Chronic administration of amitriptyline resulted in a marked increase in 5-HT1A receptor-stimulated [35S]GTPγS binding in the hippocampus which was accompanied by an increase in 5-HT1A receptor number. 5-HT 1A receptor-stimulated [35S]GTPγS binding in the hippocampus was also increased by chronic treatment with the highest dose of venlafaxine; 5-HT1A receptor number, however, was not significantly altered. In serotonergic cell body areas (i.e. dorsal and median raphe nuclei), 5-HT1A receptor-stimulated [35S]GTPγS binding was not altered by chronic administration of amitriptyline, sertraline or venlafaxine. Chronic TCA treatment does not desensitize somatodendritic 5-HT1A autoreceptor function. However, the lack of effect of chronic sertraline treatment on 5-HT1A receptor-stimulated [ 35S]GTPγS binding is in contrast to what has been observed previously following chronic administration of the SSRI fluoxetine, and suggests that different SSRIs may regulate somatodendritic 5-HT1A autoreceptor function differently depending on their pharmacology. Our data also suggest that the desensitization of somatodendritic 5-HT1A autoreceptors observed in electrophysiological studies following chronic venlafaxine administration is not at the level of receptor-G protein interaction. The hypothermic response in vivo to acute injection of 8-OH-DPAT was significantly attenuated following chronic treatment with venlafaxine or sertraline, but not amitriptyline.

Original languageEnglish (US)
Pages (from-to)393-406
Number of pages14
JournalInternational Journal of Neuropsychopharmacology
Volume9
Issue number4
DOIs
StatePublished - Aug 2006

Fingerprint

Receptor, Serotonin, 5-HT1A
GTP-Binding Proteins
Sertraline
Amitriptyline
Autoreceptors
8-Hydroxy-2-(di-n-propylamino)tetralin
Tricyclic Antidepressive Agents
Serotonin Uptake Inhibitors
Hippocampus
Serotonin 5-HT1 Receptor Agonists
Therapeutics
Venlafaxine Hydrochloride
Fluoxetine
Autoradiography
Antidepressive Agents
Pharmacology
Injections

Keywords

  • 5-HT receptor
  • [S]GTPγS
  • Amitriptyline
  • Quantitative autoradiography
  • Sertraline
  • Venlafaxine

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction. / Rossi, Dania V.; Valdez, Marisela; Gould, Georgianna G; Hensler, Julie G.

In: International Journal of Neuropsychopharmacology, Vol. 9, No. 4, 08.2006, p. 393-406.

Research output: Contribution to journalArticle

Rossi, Dania V. ; Valdez, Marisela ; Gould, Georgianna G ; Hensler, Julie G. / Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction. In: International Journal of Neuropsychopharmacology. 2006 ; Vol. 9, No. 4. pp. 393-406.
@article{3cd1481908db476192c17bf4fde9c4f5,
title = "Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction",
abstract = "In this study venlafaxine was administered to rats at a low, moderate or high dose; for comparison, the selective serotonin reuptake inhibitor (SSRI) sertraline and the tricyclic antidepressant (TCA) amitriptyline were also included. We evaluated, using quantitative autoradiography, the effect of these antidepressant treatments on [35S]GTPγS binding stimulated by the 5-HT1A receptor agonist 8-OH-DPAT, a measure of the capacity of 5-HT1A receptors to activate G proteins. Chronic administration of amitriptyline resulted in a marked increase in 5-HT1A receptor-stimulated [35S]GTPγS binding in the hippocampus which was accompanied by an increase in 5-HT1A receptor number. 5-HT 1A receptor-stimulated [35S]GTPγS binding in the hippocampus was also increased by chronic treatment with the highest dose of venlafaxine; 5-HT1A receptor number, however, was not significantly altered. In serotonergic cell body areas (i.e. dorsal and median raphe nuclei), 5-HT1A receptor-stimulated [35S]GTPγS binding was not altered by chronic administration of amitriptyline, sertraline or venlafaxine. Chronic TCA treatment does not desensitize somatodendritic 5-HT1A autoreceptor function. However, the lack of effect of chronic sertraline treatment on 5-HT1A receptor-stimulated [ 35S]GTPγS binding is in contrast to what has been observed previously following chronic administration of the SSRI fluoxetine, and suggests that different SSRIs may regulate somatodendritic 5-HT1A autoreceptor function differently depending on their pharmacology. Our data also suggest that the desensitization of somatodendritic 5-HT1A autoreceptors observed in electrophysiological studies following chronic venlafaxine administration is not at the level of receptor-G protein interaction. The hypothermic response in vivo to acute injection of 8-OH-DPAT was significantly attenuated following chronic treatment with venlafaxine or sertraline, but not amitriptyline.",
keywords = "5-HT receptor, [S]GTPγS, Amitriptyline, Quantitative autoradiography, Sertraline, Venlafaxine",
author = "Rossi, {Dania V.} and Marisela Valdez and Gould, {Georgianna G} and Hensler, {Julie G.}",
year = "2006",
month = "8",
doi = "10.1017/S1461145705005754",
language = "English (US)",
volume = "9",
pages = "393--406",
journal = "The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "4",

}

TY - JOUR

T1 - Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction

AU - Rossi, Dania V.

AU - Valdez, Marisela

AU - Gould, Georgianna G

AU - Hensler, Julie G.

PY - 2006/8

Y1 - 2006/8

N2 - In this study venlafaxine was administered to rats at a low, moderate or high dose; for comparison, the selective serotonin reuptake inhibitor (SSRI) sertraline and the tricyclic antidepressant (TCA) amitriptyline were also included. We evaluated, using quantitative autoradiography, the effect of these antidepressant treatments on [35S]GTPγS binding stimulated by the 5-HT1A receptor agonist 8-OH-DPAT, a measure of the capacity of 5-HT1A receptors to activate G proteins. Chronic administration of amitriptyline resulted in a marked increase in 5-HT1A receptor-stimulated [35S]GTPγS binding in the hippocampus which was accompanied by an increase in 5-HT1A receptor number. 5-HT 1A receptor-stimulated [35S]GTPγS binding in the hippocampus was also increased by chronic treatment with the highest dose of venlafaxine; 5-HT1A receptor number, however, was not significantly altered. In serotonergic cell body areas (i.e. dorsal and median raphe nuclei), 5-HT1A receptor-stimulated [35S]GTPγS binding was not altered by chronic administration of amitriptyline, sertraline or venlafaxine. Chronic TCA treatment does not desensitize somatodendritic 5-HT1A autoreceptor function. However, the lack of effect of chronic sertraline treatment on 5-HT1A receptor-stimulated [ 35S]GTPγS binding is in contrast to what has been observed previously following chronic administration of the SSRI fluoxetine, and suggests that different SSRIs may regulate somatodendritic 5-HT1A autoreceptor function differently depending on their pharmacology. Our data also suggest that the desensitization of somatodendritic 5-HT1A autoreceptors observed in electrophysiological studies following chronic venlafaxine administration is not at the level of receptor-G protein interaction. The hypothermic response in vivo to acute injection of 8-OH-DPAT was significantly attenuated following chronic treatment with venlafaxine or sertraline, but not amitriptyline.

AB - In this study venlafaxine was administered to rats at a low, moderate or high dose; for comparison, the selective serotonin reuptake inhibitor (SSRI) sertraline and the tricyclic antidepressant (TCA) amitriptyline were also included. We evaluated, using quantitative autoradiography, the effect of these antidepressant treatments on [35S]GTPγS binding stimulated by the 5-HT1A receptor agonist 8-OH-DPAT, a measure of the capacity of 5-HT1A receptors to activate G proteins. Chronic administration of amitriptyline resulted in a marked increase in 5-HT1A receptor-stimulated [35S]GTPγS binding in the hippocampus which was accompanied by an increase in 5-HT1A receptor number. 5-HT 1A receptor-stimulated [35S]GTPγS binding in the hippocampus was also increased by chronic treatment with the highest dose of venlafaxine; 5-HT1A receptor number, however, was not significantly altered. In serotonergic cell body areas (i.e. dorsal and median raphe nuclei), 5-HT1A receptor-stimulated [35S]GTPγS binding was not altered by chronic administration of amitriptyline, sertraline or venlafaxine. Chronic TCA treatment does not desensitize somatodendritic 5-HT1A autoreceptor function. However, the lack of effect of chronic sertraline treatment on 5-HT1A receptor-stimulated [ 35S]GTPγS binding is in contrast to what has been observed previously following chronic administration of the SSRI fluoxetine, and suggests that different SSRIs may regulate somatodendritic 5-HT1A autoreceptor function differently depending on their pharmacology. Our data also suggest that the desensitization of somatodendritic 5-HT1A autoreceptors observed in electrophysiological studies following chronic venlafaxine administration is not at the level of receptor-G protein interaction. The hypothermic response in vivo to acute injection of 8-OH-DPAT was significantly attenuated following chronic treatment with venlafaxine or sertraline, but not amitriptyline.

KW - 5-HT receptor

KW - [S]GTPγS

KW - Amitriptyline

KW - Quantitative autoradiography

KW - Sertraline

KW - Venlafaxine

UR - http://www.scopus.com/inward/record.url?scp=33745529490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745529490&partnerID=8YFLogxK

U2 - 10.1017/S1461145705005754

DO - 10.1017/S1461145705005754

M3 - Article

C2 - 16035959

AN - SCOPUS:33745529490

VL - 9

SP - 393

EP - 406

JO - The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)

JF - The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)

SN - 1461-1457

IS - 4

ER -